The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
From today's Times:
"Clients who entrusted their cash to Jupiter's fund management star stockpicker Ben Whitmore pulled £1.1bn net out of the business in the 3 months up to March after he announced he was leaving to set up his own firm".
Hope Jupiter find somebody as good to replace him!
Thanks for that. I expected dividend to be heavily reduced so a pleasant surprise!
Does anybody know the date BRWM report their results. Would have thought it would have happened by now.
Looking at Jupiter I see that the special dividend was a "one-off" covering the termination of the share buy back programme. What is the feeling about future interim dividends, will these be calculated in the same way as the final dividend and perhaps be 50% of that figure (all things being equal) and is it likely to be accompanied by a small special representing a return of capital. Interested in hearing board members views / opinions.
I like the company for the views that have been echoed on this board but am trying to build a view on future divi policy.
Read that the merger talks with GABI have been called off without a successful outcome. Was this a good move in the first place or a means of reducing debt. New to this share.
Dividend pulled in lieu of share buybacks. Disappointing.
Market looks relieved - for now. One step too far for them?
$1.77 or £1.37 GBP all in the results